Full name
APTEKA NA SURASKIEJ MAREK MORUSIEWICZ SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
APTEKA NA SURASKIEJ MAREK MORUSIEWICZ SPÓŁKA KOMANDYTOWA
UL. SURASKA 4 / 20, 15-422 BIAŁYSTOK
TAX ID5423230514
Rate company:
APTEKA NA SURASKIEJ MAREK MORUSIEWICZ SPÓŁKA KOMANDYTOWA
TAX ID5423230514
KRS0000453260
address
UL. SURASKA 4 / 20, 15-422 BIAŁYSTOK
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5423230514
REGON
200767592
KRS
0000453260
Legal form
limited partnership
Register Address
UL. SURASKA 4 / 20, 15-422 BIAŁYSTOK
Date of registration in KRS
2013-03-01
Date of commencement of economic activity
2013-03-01
Act signature
RDF/643729/24/504
Pkd codes
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.46.Z - Wholesale of pharmaceutical goods
47.29.Z - Other retail sale of food in specialised stores
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
Payer VAT status
Active
Vat list bank account(s)
PL61 1050 1953 1000 0090 8096 9711 
PL73 1050 1953 1000 0091 3397 7570 PL72 1050 1953 1000 0091 3397 7588 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 0,4 | 0,5 | 0,4 | -15,9 |
EBITDA | 0,4 | 0,5 | 0,4 | -14,8 |
Short time liabilities | 0,7 | 0,9 | 1,1 | 13,9 |
Equity capital | 0,4 | 0,5 | 0,4 | -13,9 |
Operating profit (EBIT) | 0,4 | 0,4 | 0,4 | -16 |
Assets | 1,2 | 1,5 | 1,5 | 4,6 |
Net profit (loss) | 0,4 | 0,4 | 0,3 | -16,2 |
Cash | 0,1 | 0,2 | 0,2 | 2,8 |
Liabilities and provisions for liabilities | 0,8 | 1 | 1,1 | 13 |
Net income from sale | 5,3 | 6,1 | 5,9 | -3,3 |
Working assets | 0,6 | 0,8 | 0,9 | 2,8 |
Depreciation | 0 | 0 | 0 | 66,9 |
% | % | % | p.p. | |
Profitability of capital | 88,9 | 90,9 | 88,5 | -2,4 |
Equity capital to total assets | 33,6 | 31,1 | 25,6 | -5,5 |
Gross profit margin | 7,2 | 7,4 | 6,5 | -0,9 |
EBITDA Margin | 7,2 | 7,4 | 6,5 | -0,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 49 | 56 | 66 | 10 |
Current financial liquidity indicator | 0.8799702525138855 | 0.8848622441291809 | 0.7984316349029541 | -0,1 |
Net dept to EBITDA | -0.020104877650737762 | -0.2057182341814041 | -0.2557517886161804 | -0,1 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
ELŻBIETA STĘPNIAK
Szczecin
Bioevolution sp. z o.o. sp.k.
Warszawa
Tuttomed Farmacja sp. z o.o.
Poznań
A2-POLSKA ALIAKSANDR HARDZEYUK
Biała Podlaska
"FARMEDICA" sp. z o.o.
Warszawa